Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

STHLM3 MR Phase 2: A New Diagnostic Chain for Prostate Cancer Detection Using the Stockholm3 Test and MR/Fusion Biopsies

NCT03377881 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT03377881
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03377881 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
STHLM3 MR Phase 2: A New Diagnostic Chain for Prostate Cancer Detection Using the Stockholm3 Test and MR/Fusion Biopsies
Lead sponsor
Karolinska Institutet
Phase
Not applicable
Overall status
Active, not recruiting
Start date
April 4, 2018
Completion date
December 10, 2030
Enrollment
12,750 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer